Brentuximab Vedotin in Real Life, a Seven Year Experience in Patients with Refractory/relapsed CD30+ T Cell Lymphoma.
Journal of Oncology Pharmacy Practice（2020）
关键词
Brentuximab vedotin,T-cell lymphoma,combination chemotherapy,refractory,relapse PTCL
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要